Table 5 Description of responders

From: A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen

Age

Previous chemotherapy

Response to previous chemotherapy

Site of disease

Response to vinflunine

Cycles total ( N)

Time to first response (months)

62

GC

NC

Lymph nodes

PR

7

4.2

71

GC

PD

Lymph nodes+lung

PR

6

1.3

76

CMV

PR

Lymph nodes

PR

4

1.7

71

GC

PR

Lymph nodes+lung

PR

8

1.3

50

GC

PR

Liver + lung

PR

8

1.3

79

GC

PR

Liver + lung

PR

6

2.1

64

M-VAC

PR

Lymph nodes

PR

4

1.5

63

GC

NA

Lymph nodes

PR

8

1.3

45

CMV + GC

CR

Lung

PR

5

1.1

  1. CMV=cisplatin, methotrexate, vinblastine; GC=gemcitabine, cisplatin; M-VAC=methotrexate, vinblastine, adriamycin, cisplatin.